Triptorelin Market Size & Share, by Drug Type (Pamoate, Acetate, Embonate); Application (Prostate Cancer, Radical Prostatectomy, Endometriosis, Salivary Gland Cancer, Central Precocious Puberty); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5019
  • Published Date: Jun 14, 2023
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Triptorelin Market

top-features-companies
    • Ipsen Pharma
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bachem
    • Chengdu Tiantaishan pharmaceutical
    • Ferring Pharmaceuticals
    • Tecnofarma SA
    • Dr. Reddy's Laboratories Ltd
    • Arbor Pharmaceutical, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Debiopharm International SA
    • Verity Pharmaceuticals Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • To speed up innovation in women's health, Ferring Pharmaceuticals and BioInnovation announce a new strategic partnership. The goal of the expanded partnership between the BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals A/S (Ferring) is to accelerate top-tier life science innovation in the field of women's health.
  • Treprostinil Injection, a therapeutically similar generic form of Remodulin (treprostinil) Injection, was made available on the U.S. market by Dr. Reddy's Laboratories Ltd.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5019
  • Published Date: Jun 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are the growing prevalence of HIV, the rise in prostate cancer among people, and the surge in the number of women suffering from endometriosis.

The market size of triptorelin is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Ipsen Pharma, Bachem, Chengdu Tiantaishan pharmaceutical, Ferring Pharmaceuticals, and more.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by drug type, application, distribution channel, and by region.

The triptorelin ambonate segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

High price of triptorelin drugs, side effects of triptorelin, and lack of awareness among people are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying